Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration

News   Nov 06, 2012

 
Alzheimer’s to Benefit from Landmark MRC-AstraZeneca Compound Collaboration
 
 
 

RELATED ARTICLES

Quest Diagnostics to Acquire Cleveland HeartLab

News

Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.

READ MORE


DataArt Joins Biotechnology Association BIO Deutschland

News

Global technology consultancy DataArt announced today that it has joined BIO Deutschland, Germany's biotechnology industry association.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE